Medline Industries
Medline Industries, Inc., a leading global manufacturer and distributor of healthcare supplies, is headquartered in the United States. Founded in 1910, the company has established a strong presence in North America and beyond, serving hospitals, nursing homes, and other healthcare facilities. Medline is renowned for its extensive range of products, including surgical instruments, medical apparel, and infection prevention solutions, all designed to enhance patient care and operational efficiency. With a commitment to innovation, Medline has achieved significant milestones, such as expanding its product lines and investing in advanced manufacturing technologies. The company holds a prominent market position, recognised for its quality and reliability, making it a trusted partner in the healthcare industry. Medline's dedication to customer service and tailored solutions further distinguishes it in a competitive landscape.
DitchCarbon Score
How does Medline Industries's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medline Industries's score of 41 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medline Industries's reported carbon emissions
In 2023, Medline Industries reported total carbon emissions of approximately 7278301000 kg CO2e, with Scope 1 emissions at about 173837000 kg CO2e, Scope 2 emissions at approximately 131904000 kg CO2e, and a significant contribution from Scope 3 emissions, which totalled around 6972560000 kg CO2e. The Scope 3 emissions breakdown includes categories such as purchased goods and services (5677074780 kg CO2e) and upstream transportation and distribution (400306555 kg CO2e). For 2024, Medline's emissions data indicates Scope 2 emissions of about 11850 kg CO2e and Scope 3 emissions of approximately 320260 kg CO2e in the UK, while global data for the same year shows Scope 3 upstream transport and distribution emissions at about 320260 kg CO2e. Medline Industries has set ambitious climate commitments, aiming for Net Zero emissions by 2050. The company plans to reduce its Scope 1 and Scope 2 emissions to near zero by 2025 and has committed to a 30% reduction in both Scope 1 and Scope 2 emissions from a 2023 baseline by 2030. Additionally, they project a 25% reduction in Scope 3 emissions by 2030, focusing on specific sub-categories required by the NHS. These targets reflect Medline's long-term strategy to address climate change and align with industry standards for sustainability. The emissions data and reduction initiatives are not cascaded from a parent company, indicating that Medline Industries operates independently in its climate reporting and commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2019 | 2020 | 2021 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 45,201,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 81,309,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 3 | 90,611,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medline Industries is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
